Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadonilimab + Chemotherapy + Chidamide in Advanced Gastric Cancer
ChiCTR2500096832Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Feb 2025
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cadonilimab and tucidinostat in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma (2 arms), sponsored by First Affiliated Hospital of Soochow University. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
cadonilimabtucidinostat
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on ChiCTR2500096832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096832.